<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 166 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page165.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=166">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 166 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 166</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=166"><img src="../thumb/166.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Cardio-Vascular Agents / Blood and Haemopoeitic- 7.8 / 8 / 8.1                 2020-04 / 135
       Hypoproteinaem: Adults: 50-75 g admin.IV  meds.not est., monit.centr.ven. press. esp.dur.init.infus.& observ.for   854522-018: 50 ml bot., R320,17
       Plasma exchange/dialys: 20% sol.only: Adults: Admin.25 g   circul. overload, monit.urin.output careful.& discont.if no incr, urine   820342-009: 200 ml bot., R1 280,68
       as IV infus.with rate not exceed.30 ml/ min.dur.plasma exchange.  output observ.until.adeq.diures.devel., benef./ risk outweigh.in wom-  Dosage: Reconstit.as per manufact.instructs. Dos. & infus.rate
       Contraindications: Where hypervolaem./ haemodilut. represents   en of child-bear.age esp.dur. early pregn., bld.withdr.for lab.tests to   based on clinic.pic.& results of coagulat. tests. Coagulat.factor lev-
       spec.risk, safety in pregn. not est.  be done prior to init.ther., poss.prolong.bleed.time with excess.dos.  els should be maintain. above 30% of norm.values. Init:12-15 ml/ kg
       Side effects: N&V, incr.salivat., febr.reacts., chills, flush., urticar.,   Drug interactions: Synergist.eff.with concom. anticoags.  is gen.adeq. Admin.suffic.vol.to stop bleed. & maint.haemostas. In
       fev., pulm.oed.                                            massive transfus. one plasma unit aft.every three units of pack.cells
       Special precautions: In burns & sev.shock.pts. defer admin.till   VOLULYTE, Fresenius Kabi  is advis. Monit.clinic.respon.& meas.PT/PTT/ specif. fact.assays,
       phase of maxim.capill.permeabil. to albumin molecul.is over ie.first   Poly (O-2-hydroxyethyl) starch 60 g, Na acet. trihydrat. 4,63 g, NaCl   Vol.& freq.of plasma exchng. vary depen.on indiv.pt./clinic.situat./
       24 hrs., discont. immed. in case of ac.allerg.shock, card.insuffic. pts.,   6,02 g, KCl 0,30 g, Mg chlor. hexahydr.0,30 g/ 1000 ml  preferr. treatm. regimen. Plasma vol.exchanged is usual. equiv.to the
       monit.coagulat.& haematocrit if large vols. replac., serum gluc.monit.  Indications: In conjunct.with crystall.for ac. hypovolaem. assoc.  plasma vol.of the pt. As guideline a course of 4-5 plasma exchange
       in diab.when using 4% sol., reg.bld.monitor.to ensure substitut.of   with trauma &/ surg.in adults and paed.pts.excl.neonates to restore   procedures within 7-10 days is gen.follow. Due to poss.citrate toxic.
       other bld. constit., poss.infect.dis.due to transmiss.of infect. agents,   haemodynam. stabil.  infus.rate should not exceed 1 ml/kg bm/min.
       benef.-risk ratio in pregn., 20% also: maint.adeq.hydrat.& monit.to   (S3) INFUS.SOL, 41/8.4/0211  Contraindications: Hypersens.to plasma prot. incl. pts.with IgA
       guard against circulat. overload & overhydrat., if reqd.vol.of albumin   715726-001: 1x500 ml, R426,91  defic., sev.prot.S defic.
       20 % exceeds 200 ml admin.addit.electr. sol. to maint.norm.fluid bal./  Dosage: IV infus.only. Infus.rate determ.by sev.of hypovolaem. Max.  Side effects: Cutan.manifestat., dysphon., agitat., GI disturbs., cit-
       cont.therapy with albumin 4 %,.eosinophilia myalg.syndr.assoc.with   dos.30 ml/kg/24 hrs for adults & treatm. dur. of 24 hrs.not to be ex-  rate toxic.(hypocalcaem.), hypotens., card.-resp.collapse from infus.
       L-tryptophan intake.          ceed. Infus.init. 10-20 ml slow.und.clos.observat.for poss. anaphy-  prot. hypersens./anti-IgA, tachycard., flush.skin, vasodilat., pulm.
                                     lact. reacts. Childr.&lt;12 yrs: Dos.should not exceed 15 ml/kg/24 hrs.
       GELOFUSINE, B Braun Medical   Contraindications: Critic.ill pts.with/without sepsis/ septicaem.,   manifaestat.incl.brochosp.& dyspn., chills with/without fev., back/
                                                                  substern. pain., allerg.reacts., anaphylact.reacts.
       Succinylat.gelatin (20)40 g, NaCl (3,51)7,01 g, Na Hydrox. (0,68)1,36 g,   sev.burns, mod.to sev.ren. impairm./ dehydrat., sev.hepat.impairm.,   Warnings and special precautions: CV effs. with high infus.
       Na  (77)154 mmol, Cl (60) 120 mmol/(500)1 000 ml.  overhydrat. with/without pulm.oed., CCF, ren.fail. with oligur./anur.not   rates., resuscitat.equipm.& meds. avail., dimin.card.reserve be-
        +
                -
       Indications: Prevent.& treatm.of hypovolaem., haemodilut.  due to hypovolaem., concom. dialys., IC bleed., sev.hypernatraem./   cause of circulat. overload & pulm.oed., not for use as vol.expand.
       (S3) IV INFUS. 31/8.4/0360.   hyperchloraem., starch allergy, safety in pregn.& lactat. not est., safety   where no coagulat.defic.is pres/in coagulat.fact. defic. where req.
       704084-002: 20x500 ml ecobags, R5 797,22  & effic.in pts.over 65 yrs not est., pre-exist.coagulat./bleed.disords.  specif.fact.conc.avail., poss. Parvovirus B19 infect.risk.with benefit
       Dosage: Tot.dos., durat.& rate determ.by bld./ plasma loss & pts.  Side effects: Bld.coagulat.disturbs.depend.on dos., anaphylact.  vs risk in pregn., consid.appropr.routine vaccinat.bef.admin. human
       condit.to be adjust.accord.to clinic.paramet. Warm to no more than   reacts.e.g.flu-like sympt./ bradycard. /tachycard./bronchosp./non-  bld./plasma prod.to prev.poss.infect.dis. also of unknown/emerg-
       37ºC bef.admin. Infus. 1st 20-30 ml slowly & careful observat.to de-  card.pulm. oed., prurit.aft.prolong.admin., incr.amylas.conc., poss.
       termine anaphylax.risk.       result.bld.compon.dilut.with dilut.eff.dur. high dos.admin.  ing vir.transmiss.
                                                                  Interactions: Do not mix or use concom.with other meds.as inacti-
       Hypovolaem.& hypotens.prevent.& mild hypovolaem: 500-  Warnings and special precautions: Correct underly. hypovol-
       1 000 ml.                     aem.cause & pt.monit.contin., discont. ther.if hypersens.reacts.oc-  vat./precipitat., sol.contain Ca should not be admin. through the same
                                                                  IV line because of poss.clot format.,
       Sev.hypovolaem: 1 000-2 000 ml.  cur & init. appropr. emerg.treatm., organ transpl.pts., bleed. tend.&/
       Emerg.& life threaten: 500 ml rapidly und. press. then aft.improv.  coagulopathy, poss.bleed.risk dur. cardiothorac. surg., avoid fluid   CYKLOKAPRON, Pfizer [P/S]
       of CV parameters admin. quantity equiv.to vol.loss.  overload esp.in card. insuff./sev.kidn.dysfunct., admin.crystall. sol.1   st  Tranexamic acid.
       Haemodilut: Admin.equiv.of plasma removed. Gen.no more than   in cases of sev.dehydrat., avoid mix.with other drugs, sev. electrol.  Indications: Short-term treatm.of hyphaema, pts.with est.coagu-
       20 ml/kg bm/day. Therapeut. limit is depend.on dilut.eff. If haema-  imbal.e.g.hyperkalaem./ hypernatraem./ hypermagnesaem./ hyper-  lopathies undergo.min.surg., dent.extract.in haemophil., heredit.
       tocrit falls bel. 25% (in CV/pulmon.risk pts 30%) erythocytes/ full bld.  chloraem., reg.kidn.funct./ser.electrol. monit., sev.liv dis., sev.bld.  angioneurot. oed., menorrhag.
       to be consid. Max.rate of infus.depend.on state of card. circulat. Rate   coagul.disords.incl.von Willebrand’s dis., suffic.fluid intake, concom.  (S4) INJ, [P/S] H/8.1/806. 500 mg/5 ml.
       may be incr.by apply.press.to contain./use of pump set.  prod. caus.Na/KCl retent., incr.amylase ser.conc.poss. interfer.with   717150-003: 5x5 ml, R487,92
       Contraindications: Hypervolaem./hydrat., sev. card.insuffic., sev.  pancreatit.diagn., simil.prod.contain. hydroxyethyl starch 130/0,4   Dosage: Admin.by slow IV inj/infus. When applicable change from
       bld.clott.disords., childr.und. 1 yr., safety in pregn.& lactat.not est.  in isoton.NaCl sol. prefer.in metabol.acidos./clinic.situat.where al-  parenter.admin.to oral admin.aft.a few days. Inj.IV slow.over at least
       Side effects: Anaphylactoid/anaphylact.reacts.  kalisat. should be avoid.  5 mins. & when infus. IV it may be mix.with electrol. / carbohydr.sol.,
       Special precautions: Bear in mind poss.risk of circulat.overload   Aminosol & dextr.sols. Heparin solut.may be add.
       by too rapid infus./inappropr. large dos. Infus:1st 20-30 ml slowly   VOLUVEN, Fresenius Kabi  (S4) TABS, [P/S] H/8.1/807.
       & und.caref. observat.to determine anaphylax.risk, hypernatraem.,   Poly (O-2-hydroxyethyl) starch 60 g, NaCl 9 g/ 1000 ml  717134-016: 500 mg, 100, R813,61
       dehydrat., contr.fluid electrol.& fluid bal., replace electrol.as reqd.,   Indications: In conjunct with crystalloids for ac. hypovolaem.assoc.  Dosage: Traumat.hyphaem: 1-1,5 g 8 hrly.x6-7 days.
       bld.clott. disturbs., ren.insuffic., chron.liv.dysfunct., check compati-  with trauma &/surg.in adult and paed. pts.excl.neonates, to restore   Establish.coagulopathy pts.undergo.min.surg: Cerv. conizat:
       bil.if mix.with other drugs.  haemodynam. stabil.          1-1,5 g (2-3 tabs) 8-12 hrly for 12 days post-op.
                                     (S3) INFUS.SOL, 34/8.4/0417
       RHEOMACRODEX 10% in norm.saline, (Ascendis Pharma)   897303-001: 1x500 ml, R426,73  Dent.proced: 25 mg/kg 2 hrs pre-op with Factor VIII and Factor IX
       Akacia                        Dosage: Not recomm.in pts.more than 65 yrs of age.  then 25 mg/kg 3-4 xdly for 6-8  days post-op.
                                                                  Heredit.angioneurot.oed: 1-1,5 g 2-3 xdly for some days.
       Dextran 40 100 g, NaCl 9 g/1 000 ml.  IV infus.only. Infus.init.10-20 ml slow.und.clos. observat. for poss.
       Indications: Adj.treatm.of shock/impend.shock, sole primer/addit.in   anaphylact.reacts. Infus.rate determ. by sev.of hypovolaem. Do not   Menorrhag: 2-3 tabs.3-4 xdly giv.at onset of bleed.& durat.of per.
       pump oxygenat.as priming fluid dur.extracorpor circulat.  exceed max. dos. of 30 ml/kg/24 hrs.for adults & treatm.durat. not   Contraindications: In massive upper urin.tract. haemorrh.avoid
       (S3) IV INFUS, E/8.4/207      exceed. 24 hrs. Ensure compatabil.bef.mix.with other drugs. Chil-  antifibrinolytic.to reduc. ureter. obstruct.risk, thrombot.tenden., col.
       852813-007: 500 ml, R564,68   dr.&lt;12 yrs: Do not exceed 15 ml/ kg/24 hrs.  vis.disord., thrombophlebit., imp.liv.funct., subarachn.bleed., safety
       Dosage: IV infusion only. Assessm.of pt.hydrat. imperat.bef.init.infus.   Contraindications: Critic.ill pts.with/without sepsis/ septicaem.,   in pregn.not est., not for IV mix.with blood/ solut.contain.penicill.
       Adjust accord.to nature of case and subseq.clinic.course.   sev.burns, mod.to sev.ren. funct. impairm./dehydrat., sev.hepat.  Side effects: Pass.into breast milk, GI disords., giddin., colour vis.
       Reduc.capillary circulat: Init.500 ml - 1 L IV within 30 to 60 min.,   impairm., overhydrat. with/-out pulm.oed., CCF, starch allergy, ren.  disturbs., hypotens., dizzin.
       follow.by another 500 ml later the same day thereaft.500 ml/day up   fail.with oligur., anur., intracran. bleed., sev.hypernatraem.or sev.hy-  Warnings and special precautions: Ren. impairm., lactat., dis-
       to a total of 5 days.         perchloraem., pts. receiv.dialys., safety & effic.in pts.over 65 yrs. not   cont.if col.vis.disturbs.exper., thrombo-embol.dis.hist., reg.ophthalm.
       Phlebothrombos.& imp.arter.& ven.circulat: Init.500 ml-1 L   est., safety in pregn.& lactat.not est., interacts. with other meds.not   exam.advis. bef.start.& dur.treatm.if long.than few days, concom.
       (10-20 ml/kg body weight) IV over 4 to 6 hrs on the 1st day. There-  stud., pre-exist.coagulat./ bleed. disords.  meds.with action on haemostas., potent. for thrombus format.poss.
       aft.500 ml over 4 to 6 hrs on 2  day, rep.on alt.days for up to 2 wks.  Side effects: Dos.depend.bld coagulat.disturbs., anaphylact. reacts.  incr.with concom. oestrog.
                    nd
       Post-op thrombos.prophylax: 500 ml by slow infus. commenc.dur./  eg flu-like sympts./bradycard./ tachycard./ bronchosp./non-card.pulm.  DDAVP, Ferring [P/S] &
       immed.follow.surg.to reduc. poss.anaphylact.complicat.to a min. Fur-  oed., prurit. aft. prolong.admin., incr.amylas.conc., bld. compon. dilut.  Desmopressin.
       ther treatm. depend.on est.thrombos.risk, namely:  with dilut.eff.dur.high dos.admin.  Indications: Mild haemophil.A & von Willebrand’s dis.(type l).
       Aveg.thrombos.risk: (i.e. gen.surg.pts etc.) Init. 500 ml dur.surg.   Warnings and special precautions: Correct underly. cause for hy-  (S4) INJ. S/8.1/360. 4 µg/ml.
       May be supplem.by a further 500 ml over 4 to 6 hrs on follow.day.  povolaem. & monit.pt.contin., hypernatraem., hyperchloraem., organ   717754-006: 10x1 ml, R1 115,04
       High thrombosis risk: (i.e.hip fractures, abdom. or prostatic malig-  transpl., bleed. tenden. &/ with coagulopathy, poss.bleed. risk dur.   Dosage: Admin.antifibrinolyt.agent concurr. IV admin: 0,3 µg/kg. Dil.
       nancy, prolong.immobilization, a history of thrombosis, etc.). Initially   cardiothorac.surg., avoid fluid overload esp. in card.insuffic./sev.kidn.  in 10-50 ml NaCl & infus. slow. over 15-30 mins.
       500 ml during or immediately after surgery. Repeat on the follow. day   dysfunct., admin. crystalloid sol.1  in cases of sev.dehydrat., pulm.   If used pre-op admin.30 mins.bef.proced. See prod. lit. for di-
                                                   st
       over 4 to 6 hours and then on alternate days for up to two weeks.  oed., sev.liv dis., sev.bleed.disords., monit.kidn. funct./ fluid bal./ser.  rects.for use.
       Vascular and plastic surgery: 500 ml intravenously immediately   electrol./Hb/haematocrit/ coagulat. fact/bld.platel.& plasma prot.  Contraindications: Safety in pregn.& lactat.not est., Type llB Von
       pre-op over 30 to 60 minutes, followed by another 500 ml during   bef./dur.& aft. treatm., discont.immed.in case of anaphylact. react.   Willebrand’s dis.
       the operation. Post-operatively 500 ml over 4 to 6 hours. Thereaf-  & init.appropr.treatm., poss.ser.amylas.conc. incr. which may inter-  Side effects: Tachycard., headaches, mild abdom. cramps, N&V, fac.
       ter, 500 ml over 4 to 6 hours every other day for up to two weeks.  fer.with pancreatit.diagn.  flush., vulv.pain, water intoxicat. from overhydrat.
       Shock: Suggested total dose for the first twenty-four hours should   Special precautions: Fluid overload.in haemophil., heart dis., hyper-
       not exceed 1 L (20 ml/kg body weight). Infuse first 500 ml as rapidly   tens., cyst.fibros., sensitiv. test in pts. hypersens. to ADH, large dos.
       as necess. to effect improvement. Monitor central venous pressure   pressor eff.in anaesth., pts.tak.ganglion/adrenerg. neur. block.or sym-
       as an infusion guide. Dly.dos.aft.the first 24 hours, should continued   8   BLOOD AND    pathet.outflow defects, myocard. ischaem. induc./exacerb., pregn.
       treatm.be necessary, should not exceed 500 ml (10 ml/kg body weight)   Drug interactions: Indomethac.incr.magnit.of respons., glibencla-
       and ther.should not be continued beyond five days.  HAEMOPOEITIC  mide may reduc.antidiuret. respons., carbamazepine may prolong act.
       Extracorporeal perfusion: Dose dependent on the volume needed   Warnings: Overhydrat., not suit.for infts.und.3 mnths., monit.factor
       to prime pump oxygenator. Usual total dose of between 500 ml to   VIII assay bef.& 20 mins.post infus. for respons.& if activ.less than
       1 L (10 ml to 20 ml/kg body weight) is added to the perfusion circuit.   5% of normal DDAVP should not be relied upon.
       Total dose should not exceed 2 g Dextran 40/kg body weight, and  8.1  Haemostatics  See also MDR page 315-320.
       this can be limited and controlled by adding other priming fluids.   DDAVP (MDR Listing)
       Refer to manuf.lit.                                        FEIBA, AI Crit.Care [P/S]
       Contraindications: Sev.CHF, ren.dis., thrombocytopen., hypofibrino-  BIOPLASMA FDP, NBI [P/S]  Prepar.from human plasma anti-inhibit.coag. complex with std.factor
       genaem., safety in pegn.not est.   Fresh human plasma deriv.from pool.human plasma, test.& found   eight inhibit.bypass acitvit. 0,7-2,5 U/mg protein and factor II,IX & X
       Side effects: Hypersens./allerg.reacts., skin reacts., N&V, bron-  non-react.to HBsAg & antibodies to HCV, HIV-1 & HIV-2 viruses,   mainly in non-activat. form & fact.VII in activat. form.
       chosp., abrupt hypotens., anaphylax., ren.fail., ac.pulm.oed.  prepar. using solv.-deterg.treatm.process, inactivat. lipoprot.-coat.  Indications: Treatm.& prophylax.of haemorrh.& cover surg.intervent.
       Special precautions: Reduc.ren.funct., admin. appropr.parenter.  virus.incl.HIV, hepatit.B & C.  in Haemophilia A pts.with F VIII inhibit., haemophilia B pts.with F IX
       fluid in case of dehydrat., osmot. diuret.eg.mannitol may maint.  Indications: Where plasma and/or coagulat.fact. reqd.  inhibit., eliminat.of fact.VIII inhibit./reduct. of titre in combinat.with
       urine excret., caref. pt.monit.for 30  mins.aft.treatm.start.& discont.   (S4) LYOPHILIS.IV INFUS POWD, 28/30.3/405. Min.0,4 IU/ml   Fact.VIII conc., non haemophil.with acquir.inhibit.to fact.VIII, XI & XII
       treatm. immed.in case of adverse effs., compatibil. with add.solut./  of each coagulat.fact.(II, V, VIII, IX, & XI), 4-6 g/100 ml plasma prot.  and von Williebrand’s dis.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page165.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page161.html">161</a>&nbsp;&nbsp;&nbsp;<a href="page162.html">162</a>&nbsp;&nbsp;&nbsp;<a href="page163.html">163</a>&nbsp;&nbsp;&nbsp;<a href="page164.html">164</a>&nbsp;&nbsp;&nbsp;<a href="page165.html">165</a>&nbsp;&nbsp;&nbsp;<a href="page166.html">166</a>&nbsp;&nbsp;&nbsp;<a href="page167.html">167</a>&nbsp;&nbsp;&nbsp;<a href="page168.html">168</a>&nbsp;&nbsp;&nbsp;<a href="page169.html">169</a>&nbsp;&nbsp;&nbsp;<a href="page170.html">170</a>&nbsp;&nbsp;&nbsp;<a href="page171.html">171</a>
             </td>
             <td width="35%"><a href="page167.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page167.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
